Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences

robot
Abstract generation in progress

Gilead Sciences, Inc. (Nasdaq: GILD) announced that its executives will be presenting at four investor conferences in May and June 2026, including the BofA Securities, RBC Capital Markets, Bernstein, and Goldman Sachs conferences. Live webcasts and replays will be available on the company’s investors page. Gilead, a biopharmaceutical company, focuses on developing medicines for life-threatening diseases such as HIV, viral hepatitis, COVID-19, and cancer.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin